New children’s clinical trial for autism symptoms
The Servier study is for children with autism and is testing a medication called bumetanide to determine if it can help improve certain symptoms such as being more attentive, willing to participate and open to the world as well as helping improve aggression, agitation and hyperactivity.
We understand that all children with autism are unique and there are many fantastic benefits of neurodiversity as evidenced by numerous skill and attributes exhibited. However, some children struggle with their symptoms and and may want to seek help.
We are currently recruiting children and adolescents with a diagnosis of autism or a suspected diagnosis, aged 2-17 years to participate in the Servier clinical trial.
To register your interest please fill out the form below: